Diabetes
New data from the United States, Canada and Austria lluminates research in diabetes
Published in Obesity and Diabetes Week, June 19th, 2006
Study 1: Incretin mimetics and dipeptidyl peptidase-IV inhibitors offer potential new therapies for type 2 diabetes mellitus.
According to a recent review from the United States, "The emergence of the glucoregulatory hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide has expanded our understanding of glucose homeostasis. In particular, the glucoregulatory actions of the incretin hormone GLP-1 include enhancement of glucose-dependent insulin secretion, suppression of inappropriately elevated glucagon secretion, slowing of gastric...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Epidemiology
Maintenance of leanness in adolescences and adulthood can prevent type 2 diabetes - Diabetes Therapy
Etanercept reduces C-reactive protein levels in patients with the metabolic syndrome - Diet & Nutrition
N-3 Fatty acids modulate antioxidant status in diabetic rats and macrosomic offspring - Obesity Pathogenesis
Lipid metabolism and adipokine levels are altered in fatty acid-binding protein null mice - Obesity Pathogenesis
LKB1-AMPK signaling in muscle from obese insulin-resistant rats can be restored by training - Arthritis
Risk factors for lack of recent exercise in adults with arthritis are assessed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
